Group 1 - The "South Wing New Ten Policies" was released to promote the integration of technological and industrial innovation in Fuyang, aiming to transform the region into a preferred location for technology achievement conversion [2] - The policies include support for industry-academia-research cooperation, promoting the industrialization of intellectual property, and recognizing concept verification projects, addressing the core bottleneck from "laboratory" to "production line" [2] - Specific incentives include subsidies for AI public service platforms and funding for key projects in the AI manufacturing sector, with annual maximum subsidies of 2 million yuan and 1 million yuan respectively [2] Group 2 - The biopharmaceutical industry is one of the four emerging industries in Fuyang, with 58 regulated enterprises and projected revenue of 13.2 billion yuan in 2024, focusing on modern traditional Chinese medicine, biopharmaceuticals, high-end medical devices, and synthetic biology [3] - Fuyang is actively developing the "Oriental Dan Valley" as a modern traditional Chinese medicine international cooperation demonstration zone, aiming to create a "one core, multiple parks" industrial spatial layout [3] - A cooperation agreement was signed between various organizations and Fuyang Economic Development Zone, alongside the establishment of a patent navigation service base and a knowledge property alliance in the modern traditional Chinese medicine industry [4] Group 3 - Three funds focused on the biopharmaceutical sector, with a total scale exceeding 2 billion yuan, have reached cooperation agreements with Fuyang [4] - The event showcased the research strength and industrial conversion potential accumulated by Fuyang, demonstrating a positive cycle from "policy cultivation" to "results emergence" [4] - Two sub-forums were held to focus on intellectual property operation and commercialization of results, as well as to gather insights for the high-quality development of the medical device industry in Fuyang [4]

Core Points - The Hong Kong Stock Exchange (HKEX) Listing Committee decided on August 28 to maintain its decision regarding the company, indicating that it has failed to maintain sufficient business operations and does not possess adequate asset value to support its operations [1] - As a result of this decision, the company's shares will be suspended from trading starting at 9 AM today, with the last trading price recorded at HKD 0.36 [1] - The company must comply with the listing rules and any potential resumption guidelines set by HKEX before trading can resume; failure to trade for 18 consecutive months may lead to the cancellation of its listing status [1]

Core Viewpoint - The company has announced that its shares will be suspended from trading starting at 9 AM on September 9, 2025 [1] Group 1 - The suspension of trading is effective immediately as of the specified date and time [1]

Core Viewpoint - Fuyuan (00352.HK) announced that its shares will be suspended from trading starting at 9:00 AM on September 9, 2025 [1] Company Summary - The trading suspension of Fuyuan shares is effective immediately as of the specified date [1]

Core Viewpoint - Fuyuan (00352) announced that its shares will be suspended from trading starting September 9, 2025, at 9:00 AM [1] Group 1 - The company has officially communicated the suspension of its shares [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Fortune Sun (China) Holdings Limited 富陽（中國）控股有限公司 （於開曼群島註冊成立之有限公司） 本 公 司 股 份 將 自 二 零 二 五 年 九 月 九 日 上 午 九 時 正 起 暫 停 於 聯 交 所 買 賣。 在 允 許 恢 復 買 賣 前，本 公 司 必 須： – 1 – (1) 重新符合上市規則第13.24條 之 規 定； (2) 達 成 聯 交 所 可 能 施 加 的 任 何 復 牌 指 引；及 (3) 使 聯 交 所 信 納 其 全 面 遵 守 上 市 規 則。 （股份代號：00352） 暫停股份買賣 本 公 告 乃 由 富 陽（中 國）控 股 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有 限 公 司 （「聯交所」）證 券 上 市 規 則（「上市規則」）第13.24條以及香 ...

Core Viewpoint - The company Fuyang (00352) announced that the Stock Exchange Listing Committee has decided to maintain its decision under Listing Rule 13.24, leading to a suspension of trading for its shares starting September 9, 2025, unless a review application is submitted [1] Group 1 - The company has decided to waive its right to submit a review application under Listing Rule 2B.06(1) [1] - Shares will be suspended from trading on September 9, 2025, which is seven business days after the decision date [1] - To resume trading, the company must comply with Listing Rule 13.24, meet any resumption guidance imposed by the Stock Exchange, and ensure full compliance with the listing rules [1]

Core Points - The company Fuyang (00352) announced that the Stock Exchange Listing Committee has decided to maintain its decision under Listing Rule 13.24 [1] - Unless the company submits a review application under Listing Rule 2B.06(1), its shares will be suspended from trading starting September 9, 2025 [1] - After careful consideration, the company has decided to waive its right to submit a review application [1] Summary by Sections - **Listing Status** - The company’s shares will be suspended from trading on September 9, 2025, following the Listing Committee's decision [1] - The company must meet specific conditions to resume trading, including compliance with Listing Rule 13.24 [1][1] - **Conditions for Resumption** - The company must re-comply with Listing Rule 13.24 [1] - The company must meet any resumption guidance that may be imposed by the Stock Exchange [1] - The company must ensure full compliance with the listing rules to regain trading status [1]

Core Viewpoint - The company Fuyuan (00352.HK) has decided to forgo its right to apply for a review under Listing Rule 2B.06(1), leading to the suspension of its shares from trading starting September 9, 2025 [1] Summary by Relevant Sections - **Suspension of Trading** The company's shares will be suspended from trading as of September 9, 2025, due to the decision to abandon the review application [1] - **Conditions for Resumption** Before trading can resume, the company must: 1. Comply with Listing Rule 13.24 2. Meet any resumption guidance that may be imposed by the Stock Exchange 3. Ensure the Stock Exchange is satisfied with its full compliance with the listing rules [1] - **Potential Delisting** According to Listing Rule 6.01A(1), if the company's shares remain suspended for 18 consecutive months, the Stock Exchange may cancel the company's listing status [1]

（於開曼群島註冊成立之有限公司） Fortune Sun (China) Holdings Limited 富陽（中國）控股有限公司 （股份代號：00352） 放棄覆核及暫停股份買賣 本 公 告 乃 由 富 陽（中 國）控 股 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有 限 公 司 （「聯交所」）證 券 上 市 規 則（「上市規則」）第13.24條以及香港法例第571章《證 券 及 期 貨 條 例》第XIVA部 項 下 的 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 作 出。 茲 提 述 日 期 為 二 零 二 五 年 六 月 十 三 日、二 零 二 五 年 六 月 二 十 四 日 及 二 零 二 五 年 八 月 二 十 八 日 之 公 告（「該等公告」），內 容 有 關（其 中 包 括）聯 交 所 上 市 委 員 會 決定維持上市科根據上市規則第13.24條 所 作 出 之 決 定。除 非 本 公 司 根 據 其 於 上市規則第2B.06(1)條 項 下 所 享 有 權 利 提 交 覆 核 該 決 定 的 申 請，否 則 股 份 將 自 二 零 二 五 年 九 月 九 日 ...